Telix Pharmaceuticals Limited (ASX:TLX)

Telix Pharmaceuticals Revenue

In the year 2024, Telix Pharmaceuticals had annual revenue of 783.21M AUD with 55.85% growth. Telix Pharmaceuticals had revenue of 209.62M in the quarter ending December 31, 2024, with 48.82% growth.

• Revenue: 783.21M
• Revenue Growth: +55.85%
• P/S Ratio: 11.35
• Revenue / Employee: 1.85M
• Employees: 234
• Market Cap: 8.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	783.21M	280.66M	55.85%
Dec 31, 2023	502.55M	342.45M	213.90%
Dec 31, 2022	160.10M	152.50M	2,007.64%
Dec 31, 2021	7.60M	2.38M	45.71%
Dec 31, 2020	5.21M	1.73M	49.58%